Get the Stockscreener App
0.2242
12.10%
0.0242
After Hours:
.22
-0.0042
-1.87%
Citius Pharmaceuticals Inc Stock (CTXR) Forecast
The Citius Pharmaceuticals Inc (CTXR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.1383, representing a -38.31% decrease from the current price of $0.2242. The highest analyst price target is $0.2078, and the lowest is $0.0688.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTXR Price Target
Average 0.8598
(+283.47% Upside)
Is Citius Pharmaceuticals Inc (CTXR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.69 | Neutral |
| STOCH(9,6) | 40.60 | Neutral |
| STOCHRSI(14) | 10.25 | Buy |
| MACD(12,26) | -0.0347 | Sell |
| ADX(14) | 22.74 | Neutral |
| William %R | -88.74 | Buy |
| CCI(14) | -181.88 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.356
Sell
|
0.3308
Sell
|
| MA20 |
0.3621
Sell
|
0.3598
Sell
|
| MA50 |
0.4243
Sell
|
0.4284
Sell
|
| MA100 |
0.5698
Sell
|
0.5152
Sell
|
| MA200 |
0.6486
Sell
|
0.6104
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CTXR could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CTXR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.69 indicates that CTXR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.6 indicates that CTXR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.25 indicates that CTXR is oversold. This suggests that CTXR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.74 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -181.88 indicates that CTXR is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CTXR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Citius Pharmaceuticals Inc financial reports and earnings history, Citius Pharmaceuticals Inc (CTXR) stock could reach $0.8034 by 2030, $0.9391 by 2040 and $0.3355 by 2050. See the projected annual prices until 2050 of the Citius Pharmaceuticals Inc stock below:
- Citius Pharmaceuticals Inc (CTXR) is expected to reach an average price of $0.3023 in 2035, with a high prediction of $0.3051 and a low estimate of $0.2134. This indicates an $34.82% rise from the last recorded price of $0.2242.
- Citius Pharmaceuticals Inc (CTXR) stock is projected to chart a bullish course in 2040, with an average price target of $0.6803, representing an $203.42% surge from its current level. The forecast ranges from a conservative $0.3969 to a sky-high $0.9391.
- Our analysts predict Citius Pharmaceuticals Inc (CTXR) to jump -66.94% by 2045, soaring from $0.0411 to an average price of $0.0741, potentially reaching $0.2596. While $0.0411 is the low estimate, the potential upside is significant.
- Citius Pharmaceuticals Inc (CTXR) stock is expected to climb by 2050, reaching an average of $0.2532, a $12.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.3355 and $0.0013, respectively, highlighting the market's uncertainty.
Citius Pharmaceuticals Inc Stock (CTXR) Year by Year Forecast
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2024
Our forecast for CTXR stock price in 2024 now indicates an average price target of $0.6077 with a high forecast of $1.1467 and a low forecast of $0.0688. The average prediction reflects an increase of +171.07% from the last recorded price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.1388 | $0.0688 | $0.2078 | -38.09% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2025
Citius Pharmaceuticals Inc Stock (CTXR) is expected to reach an average price of $0.8703 in 2025, with a high prediction of $1.6507 and a low estimate of $0.0899. This indicates an +288.18% rise from the last recorded price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.6005 | $0.1392 | $0.9198 | +167.83% |
| February, 2025 | $0.8421 | $0.4732 | $1.1217 | +275.59% |
| March, 2025 | $0.4136 | $0.3937 | $0.9124 | +84.47% |
| April, 2025 | $0.2972 | $0.0899 | $0.4821 | +32.54% |
| May, 2025 | $0.3424 | $0.2962 | $0.6558 | +52.70% |
| June, 2025 | $0.4885 | $0.4674 | $0.9773 | +117.87% |
| July, 2025 | $0.5705 | $0.4488 | $0.7296 | +154.48% |
| August, 2025 | $1.0218 | $0.521 | $1.6507 | +355.77% |
| September, 2025 | $0.8133 | $0.7733 | $1.4526 | +262.77% |
| October, 2025 | $0.5151 | $0.4652 | $0.8837 | +129.76% |
| November, 2025 | $0.7267 | $0.4784 | $0.816 | +224.14% |
| December, 2025 | $0.6691 | $0.6471 | $0.9182 | +198.44% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2026
The predicted value for Citius Pharmaceuticals Inc (CTXR) in 2026 is set at an average of $2.4126. Estimates vary from a peak of $4.2621 to a trough of $0.563, indicating an +976.07% surge from the present price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6768 | $0.563 | $0.7093 | +201.87% |
| February, 2026 | $0.8066 | $0.6539 | $0.9612 | +259.77% |
| March, 2026 | $0.8231 | $0.6625 | $0.8831 | +267.13% |
| April, 2026 | $1.755 | $0.8135 | $1.855 | +682.77% |
| May, 2026 | $1.6965 | $1.1657 | $2.5954 | +656.68% |
| June, 2026 | $1.518 | $1.418 | $1.8969 | +577.07% |
| July, 2026 | $1.6599 | $1.1987 | $2.2195 | +640.35% |
| August, 2026 | $2.3014 | $1.6502 | $2.3914 | +926.48% |
| September, 2026 | $1.9032 | $1.6829 | $4.2621 | +748.90% |
| October, 2026 | $1.5647 | $1.4947 | $1.9536 | +597.92% |
| November, 2026 | $1.9562 | $1.4255 | $2.0562 | +772.54% |
| December, 2026 | $1.7481 | $1.6477 | $1.9845 | +679.72% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Citius Pharmaceuticals Inc (CTXR) is $1.2572, with a high forecast of $1.9591 and a low forecast of $0.5552. This indicates an +460.75% increase from the last price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6546 | $1.5696 | $1.9591 | +638.01% |
| February, 2027 | $1.4211 | $1.3761 | $1.7304 | +533.86% |
| March, 2027 | $1.283 | $1.2123 | $1.5826 | +472.26% |
| April, 2027 | $1.2445 | $1.1645 | $1.4441 | +455.09% |
| May, 2027 | $1.226 | $1.0253 | $1.3949 | +446.84% |
| June, 2027 | $1.2379 | $1.1271 | $1.5668 | +452.13% |
| July, 2027 | $1.5094 | $1.1283 | $1.6489 | +573.23% |
| August, 2027 | $0.9209 | $0.9109 | $1.7301 | +310.74% |
| September, 2027 | $0.6478 | $0.582 | $0.9013 | +188.92% |
| October, 2027 | $0.6054 | $0.6012 | $0.8189 | +170.01% |
| November, 2027 | $0.6631 | $0.5552 | $0.7446 | +195.75% |
| December, 2027 | $0.8976 | $0.5866 | $0.9476 | +300.38% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2028
In 2028, Citius Pharmaceuticals Inc (CTXR) is projected to reach an average price of $0.9797, with a high projection of $1.453 and a low estimate of $0.5063. This indicates an +336.96% rise from the last price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0292 | $0.8584 | $1.0584 | +359.03% |
| February, 2028 | $0.9407 | $0.8503 | $1.1095 | +319.56% |
| March, 2028 | $0.8125 | $0.7422 | $1.011 | +262.41% |
| April, 2028 | $0.924 | $0.7429 | $0.954 | +312.15% |
| May, 2028 | $0.5721 | $0.5459 | $1.0148 | +155.18% |
| June, 2028 | $1.1174 | $0.5063 | $1.2174 | +398.40% |
| July, 2028 | $1.1389 | $0.8778 | $1.2289 | +407.99% |
| August, 2028 | $0.8108 | $0.7608 | $1.0193 | +261.64% |
| September, 2028 | $1.1123 | $0.7015 | $1.1423 | +396.12% |
| October, 2028 | $1.0238 | $0.8938 | $1.453 | +356.64% |
| November, 2028 | $1.0657 | $0.7945 | $1.1942 | +375.32% |
| December, 2028 | $0.9472 | $0.9072 | $1.1472 | +322.47% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2029
The 2029 price forecast for Citius Pharmaceuticals Inc Stock (CTXR) is $0.6876 on average, with a high prediction of $1.0326 and a low estimate of $0.3426. This represents an +206.68% increase from the previous price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.739 | $0.5993 | $1.0326 | +229.60% |
| February, 2029 | $0.7184 | $0.6002 | $0.7887 | +220.41% |
| March, 2029 | $0.5112 | $0.4721 | $0.7309 | +127.99% |
| April, 2029 | $0.4511 | $0.3828 | $0.5334 | +101.19% |
| May, 2029 | $0.5254 | $0.3543 | $0.6041 | +134.36% |
| June, 2029 | $0.5299 | $0.506 | $0.5466 | +136.37% |
| July, 2029 | $0.5149 | $0.5082 | $0.6276 | +129.68% |
| August, 2029 | $0.3813 | $0.365 | $0.5888 | +70.08% |
| September, 2029 | $0.5218 | $0.3611 | $0.6214 | +132.75% |
| October, 2029 | $0.5519 | $0.4133 | $0.5822 | +146.16% |
| November, 2029 | $0.5196 | $0.4649 | $0.8344 | +131.76% |
| December, 2029 | $0.3826 | $0.3426 | $0.5652 | +70.65% |
Citius Pharmaceuticals Inc Stock (CTXR) Price Forecast for 2030
Citius Pharmaceuticals Inc Stock (CTXR) is expected to reach an average price of $0.4029 in 2030, with a high forecast of $0.8034 and a low forecast of $0.00247. This signifies an +79.71% surge from the last price of $0.2242.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3764 | $0.3264 | $0.8034 | +67.87% |
| February, 2030 | $0.3895 | $0.2279 | $0.4771 | +73.71% |
| March, 2030 | $0.5225 | $0.3401 | $0.7626 | +133.03% |
| April, 2030 | $0.3354 | $0.3354 | $0.5331 | +49.58% |
| May, 2030 | $0.0879 | $0.00287 | $0.6034 | -60.78% |
| June, 2030 | $0.0877 | $0.00247 | $0.1278 | -60.90% |
| July, 2030 | $0.229 | $0.1264 | $0.1249 | +2.15% |
| August, 2030 | $0.0158 | $0.1111 | $0.1834 | -92.96% |
| September, 2030 | $0.2629 | $0.0296 | $0.5896 | +17.26% |
| October, 2030 | $0.4356 | $0.2226 | $0.7934 | +94.31% |
| November, 2030 | $0.1145 | $0.0321 | $0.5664 | -48.95% |
| December, 2030 | $0.0932 | $0.0163 | $0.3317 | -58.45% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):